Crescent Grove Advisors, LLC Edwards Lifesciences Corp Transaction History

Crescent Grove Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$84.3 - $94.31 $44,257 - $49,512	525 Added 24.09%	2,704 $249,000
Q1 2024 Apr 29, 2024	BUY	$72.54 - $95.56 $158,064 - $208,225	2,179 New	2,179 $208,000
Q2 2023 Jul 13, 2023	BUY	$81.41 - $94.33 $176,741 - $204,790	2,171 New	2,171 $204,000
Q2 2022 Jul 20, 2022	BUY	$86.5 - $128.27 $63,404 - $94,021	733 Added 36.63%	2,734 $260,000
Q3 2021 Oct 26, 2021	BUY	$102.91 - $122.75 $205,922 - $245,622	2,001 New	2,001 $227,000

1,353

466M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.